My watch list
my.chemeurope.com  
Login  

Bayer and LANXESS to sell their stakes in Currenta

07-Aug-2019

LANXESS AG

Aerial view of Chempark Leverkusen.

Bayer and LANXESS sell their stakes in the chemical park operator Currenta to funds managed by Macquarie Infrastructure and Real Assets (MIRA). Both companies signed corresponding agreements with MIRA on August 6, 2019. The transaction still requires the approval of the responsible authorities. Currenta manages and operates infrastructure, energy supply and other essential services across the chemical parks in Leverkusen, Dormagen and Krefeld-Uerdingen and is currently a joint venture of Bayer (60%) and LANXESS (40%). Currenta, including a transferred real estate portfolio by Bayer, is valued with a total enterprise value of EUR 3.5 billion before deduction of net debt and pension obligations.

Bayer and Currenta to continue to work together closely

“We are delighted to announce that in MIRA, the world’s leading infrastructure asset manager, we have found the right partner to drive the successful development of Currenta while leveraging its international expertise,” said Dr. Hartmut Klusik, member of the Board of Management and Labor Director of Bayer AG. “In addition, MIRA has a long term focus and will also be a reliable employer for Currenta’s employees.” Bayer and MIRA have reached an agreement on long-term service and supply contracts, he added. “We will continue to work closely with Currenta moving forward,” Klusik underlined.

Bayer’s 60 percent stake in Currenta has an equity value of approximately EUR 1.17 billion (after deduction of net debt and pension obligations). In addition, in order to strengthen the Currenta Group, Bayer is selling to it an extensive package of real estate and infrastructure for EUR 180 million.

Bayer had announced in November 2018 that it was looking to sell its stake in Currenta. The main reasons behind this are that Bayer’s position as a Chempark customer has changed following the carve-out of Covestro and that Bayer has stepped up its focus on its core activities. Bayer expects its part of the transaction to close in the fourth quarter of 2019.

LANXESS safeguards strategic interest

LANXESS as one of Currenta's main customers will provide MIRA with operational support during the transition phase and will therefore continue to hold its stake in Currenta for several months longer. Thus, the company expects its transaction to be completed by the end of April 2020. The 40 percent stake of Currenta held by LANXESS accounts for an equity value (after deduction of net debt and pensions) of approximately EUR 780 million pre tax. In addition, LANXESS is entitled to a profit participation until completion of the transaction. Moreover, LANXESS has reached an agreement with MIRA on service and supply contracts for the three sites in Leverkusen, Dormagen and Krefeld which will initially run for 10 years. LANXESS operates a significant portion of its global production facilities there.

"The heart of LANXESS production beats at the Lower Rhine sites. It was therefore crucial for us that the future Currenta owner structure should safeguard our strategic interest in an industry-oriented set-up of the chemical parks. With MIRA as an experienced and strong partner and with the long-term contract package, we have achieved this and secured a reliable infrastructure at competitive conditions for the future," said Matthias Zachert, Chairman of the Board of Management of LANXESS AG. "At the same time, the sale of our stake will give us additional financial leeway to drive forward our growth course in specialty chemicals."

MIRA, a long-term partner

“MIRA is delighted to partner with Bayer and LANXESS to acquire Currenta. As a long-term owner of essential infrastructure, MIRA is committed to working with the Currenta management team to ensure the longevity and ongoing success of the business for both customers and employees,” said Hilko Schomerus, Head of Germany, MIRA.

MIRA has been active in Germany for 30 years, and has extensive experience in Currenta’s core business areas including utilities, transport, logistics, storage, waste management and treatment services. Through these investments MIRA has demonstrated its commitment to sustainability, helping to create stronger businesses that are better positioned to meet the needs of the communities they serve. Utilising this experience, MIRA intends to invest significantly to enhance Currenta’s environmental and operational performance – aiming to add real and lasting value for its customers and stakeholders.

MIRA believes Currenta’s experienced workforce are critical to the businesses’ success. As such, MIRA’s plans for Currenta ensure full continuity of service without any restructuring or any planned changes to the existing workforce. In addition, long-term contracts have been agreed with the current customers, demonstrating the commitment of all parties to the ongoing success of Currenta.

Facts, background information, dossiers
  • Lanxess
  • Currenta
  • Bayer
  • acquisitions
More about Lanxess
  • News

    LANXESS planning AI-assisted formulation development for Urethane Systems

    LANXESS is broadening its use of artificial intelligence (AI) in product development. The specialty chemicals company has launched a project aimed at expanding its range of prepolymers. The goal is to offer customers tailor-made polyurethane systems with even shorter lead times, including f ... more

    LANXESS wins Responsible Care competition 2019 of German Chemical Industry Association (VCI)

    Specialty chemicals company LANXESS received on September 26 the first prize in the nationwide Responsible Care competition from the German Chemical Industry Association (VCI). The company submitted the project “Resource-efficient manufacturing of leather chemicals” (ReeL). Responsible Care ... more

    LANXESS inaugurates high-tech plastics plant in China

    Specialty chemicals company LANXESS officially inaugurated its new plant in Changzhou, China, on September 25, 2019. The compounding facility produces Durethan- and Pocan-branded high-tech plastics, especially for the automotive sector and the electrical and electronics industry. “This faci ... more

  • Companies

    LANXESS Deutschland GmbH

    LANXESS is a leading specialty chemicals company and operates in all important markets of the world. Its core business comprises the development, manufacture and sale of high-tech plastics, high-performance rubber, specialty chemicals and intermediates. In addition, it helps its customers i ... more

    LANXESS Sybron Chemicals Inc.

    LANXESS Sybron Chemicals Inc., provides world-class ion exchange resins to meet the needs of numerous applications. The global strength of Lewatit ion exchange resins in industrial water and chemical processing markets is joined with the solid position Ionac ion exchange resins enjoy in the ... more

    LANXESS S.A.

    LANXESS is listed as the fourth largest German Chemistry Corporation in the Frankfurt Stock Exchange. With our extensive portfolio we are active in all the markets of the world. Our product pallet ranges from base, specialty and fine chemicals to plastics and rubbers. In addition, we sup ... more

More about Bayer
  • News

    Bayer reduces size of Board of Management from seven to five members

    The Supervisory Board of Bayer AG on Tuesday decided to reduce the size of the company’s Board of Management from seven to five members effective January 1, 2020. Dr. Hartmut Klusik (63) and Kemal Malik (56) will leave the company as of December 31, 2019. As part of the previously communica ... more

    Bayer: strong operational start to the year

    The Bayer Group achieved a strong start to the year in its operational business. “A major factor in this success was our agriculture business, while Pharmaceuticals also delivered encouraging performance,” said Werner Baumann, Chairman of the Board of Management, on Thursday when presenting ... more

    Bayer completes biggest acquisition in its history

    Bayer successfully completed the biggest acquisition in its history in the second quarter of 2018, while operational performance improved, even without taking into account the newly acquired Monsanto business. Sales advanced at three of the four segments on a currency- and portfolio-adjuste ... more

  • Companies

    Bayer Technology Services México

    Bayer Technology Services stands for technological competence throughout the service life of processes or units. We support our customers from the development of innovative products and processes to engineering and construction of units, to operating control and optimization – with courage, ... more

    Bayer Corporation

    Bayer Corporation, headquartered in Pittsburgh, is a subsidiary of Bayer AG, an international health care, nutrition and innovative materials group based in Leverkusen, Germany. In North America, Bayer had 2006 net sales of 7.8 billion euros and employed 17,200 at year end. Bayer’s three s ... more

    Bayer S.A./NV.

    Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Our products and services are designed to benefit people and improve their quality of life. At the same time we want to create value through innovation, growth and high earni ... more

More about CURRENTA
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE